Jiangbo Pharmaceuticals, Inc. SEC Filings

This REPAYMENT AGREEMENT ("Agreement"), is entered into as of the 17th day of July, 2011, by and between:

Laiyang, China, August 1, 2011 – Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) (“Jiangbo” or the “Company”), a pharmaceutical company with its principal operations in the People's Republic of China (“China”), today announced that it has r...

Jiangbo Pharmaceuticals, Inc. (the “Company”), held its annual meeting of stockholders on June 28, 2011, at 9:00 a.m. Beijing Standard Time (local time), which is equivalent to June 27, 2011 at 9:00 p.m. U.S. Eastern Standard Time (the “...

Laiyang, China, May 24, 2011 – Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) (“Jiangbo” or the “Company”), a pharmaceutical company with its principal operations in the People's Republic of China, today announced its third quarter fiscal ...

No securities owned

Press Release Source: Jiangbo Pharmaceuticals, Inc. On Monday May 16, 2011, 8:00 am EDT

We have read Item 4.01 included in the Form 8-K of Jiangbo Pharmaceuticals, Inc. filed with the Securities and Exchange Commission on April 20, 2011. We agree with the statements concerning our Firm in such Form 8-K; we are not in a posi...

We have read Item 4.01, and are in agreement with, the statements as they related to our firm being made by Jiangbo Pharmaceutical, Inc. in Item 4.01 of its Form 8-K filed with the SEC on April 4, 2011, captioned “Changes in Registrant’s...

Please accept this as my formal resignation as the Chief Financial Officer of Jiangbo Pharmaceuticals, Inc. (the “Company”) effective March 31, 2011. I reached this decision due to a difficult family circumstance that would not permit me...

Laiyang, China, February 23, 2011 – Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) (“Jiangbo” or the “Company”), a pharmaceutical company with its principal operations in the People's Republic of China, today announced its second quarter f...